197 related articles for article (PubMed ID: 36111986)
41. Localization of an apolipoprotein A-I epitope critical for activation of lecithin-cholesterol acyltransferase.
Banka CL; Bonnet DJ; Black AS; Smith RS; Curtiss LK
J Biol Chem; 1991 Dec; 266(35):23886-92. PubMed ID: 1721059
[TBL] [Abstract][Full Text] [Related]
42. Crystal structure of C-terminal truncated apolipoprotein A-I reveals the assembly of high density lipoprotein (HDL) by dimerization.
Mei X; Atkinson D
J Biol Chem; 2011 Nov; 286(44):38570-38582. PubMed ID: 21914797
[TBL] [Abstract][Full Text] [Related]
43. Apolipoprotein A-I (R151C)Paris is defective in activation of lecithin: cholesterol acyltransferase but not in initial lipid binding, formation of reconstituted lipoproteins, or promotion of cholesterol efflux.
Daum U; Langer C; Duverger N; Emmanuel F; Benoit P; Denèfle P; Chirazi A; Cullen P; Pritchard PH; Bruckert E; Assmann G; von Eckardstein A
J Mol Med (Berl); 1999 Aug; 77(8):614-22. PubMed ID: 10543393
[TBL] [Abstract][Full Text] [Related]
44. Natural mutations of apolipoprotein A-I impairing activation of lecithin:cholesterol acyltransferase.
Hoang A; Huang W; Sasaki J; Sviridov D
Biochim Biophys Acta; 2003 Feb; 1631(1):72-6. PubMed ID: 12573451
[TBL] [Abstract][Full Text] [Related]
45. Naturally occurring and bioengineered apoA-I mutations that inhibit the conversion of discoidal to spherical HDL: the abnormal HDL phenotypes can be corrected by treatment with LCAT.
Koukos G; Chroni A; Duka A; Kardassis D; Zannis VI
Biochem J; 2007 Aug; 406(1):167-74. PubMed ID: 17506726
[TBL] [Abstract][Full Text] [Related]
46. Disruption of the murine lecithin:cholesterol acyltransferase gene causes impairment of adrenal lipid delivery and up-regulation of scavenger receptor class B type I.
Ng DS; Francone OL; Forte TM; Zhang J; Haghpassand M; Rubin EM
J Biol Chem; 1997 Jun; 272(25):15777-81. PubMed ID: 9188474
[TBL] [Abstract][Full Text] [Related]
47. Influence of vesicle surface composition on the interfacial binding of lecithin:cholesterol acyltransferase and apolipoprotein A-I.
Miller KR; Parks JS
J Lipid Res; 1997 Jun; 38(6):1094-102. PubMed ID: 9215538
[TBL] [Abstract][Full Text] [Related]
48. Role of the Arg123-Tyr166 paired helix of apolipoprotein A-I in lecithin:cholesterol acyltransferase activation.
Dhoest A; Zhao Z; De Geest B; Deridder E; Sillen A; Engelborghs Y; Collen D; Holvoet P
J Biol Chem; 1997 Jun; 272(25):15967-72. PubMed ID: 9188498
[TBL] [Abstract][Full Text] [Related]
49. Coincubation of PON1, APO A1, and LCAT increases the time HDL is able to prevent LDL oxidation.
Hine D; Mackness B; Mackness M
IUBMB Life; 2012 Feb; 64(2):157-61. PubMed ID: 22184096
[TBL] [Abstract][Full Text] [Related]
50. Acquired lecithin:cholesterol acyltransferase deficiency as a major factor in lowering plasma HDL levels in chronic kidney disease.
Calabresi L; Simonelli S; Conca P; Busnach G; Cabibbe M; Gesualdo L; Gigante M; Penco S; Veglia F; Franceschini G
J Intern Med; 2015 May; 277(5):552-61. PubMed ID: 25039266
[TBL] [Abstract][Full Text] [Related]
51. Sphingomyelin inhibits the lecithin-cholesterol acyltransferase reaction with reconstituted high density lipoproteins by decreasing enzyme binding.
Bolin DJ; Jonas A
J Biol Chem; 1996 Aug; 271(32):19152-8. PubMed ID: 8702592
[TBL] [Abstract][Full Text] [Related]
52. Lecithin:cholesterol acyltransferase: old friend or foe in atherosclerosis?
Kunnen S; Van Eck M
J Lipid Res; 2012 Sep; 53(9):1783-99. PubMed ID: 22566575
[TBL] [Abstract][Full Text] [Related]
53. Analysis of human lecithin-cholesterol acyltransferase activity by carboxyl-terminal truncation.
Lee YP; Adimoolam S; Liu M; Subbaiah PV; Glenn K; Jonas A
Biochim Biophys Acta; 1997 Feb; 1344(3):250-61. PubMed ID: 9059515
[TBL] [Abstract][Full Text] [Related]
54. Haptoglobin binds the antiatherogenic protein apolipoprotein E - impairment of apolipoprotein E stimulation of both lecithin:cholesterol acyltransferase activity and cholesterol uptake by hepatocytes.
Cigliano L; Pugliese CR; Spagnuolo MS; Palumbo R; Abrescia P
FEBS J; 2009 Nov; 276(21):6158-71. PubMed ID: 19758344
[TBL] [Abstract][Full Text] [Related]
55. Lipid-free apolipoproteins A-I and A-II promote remodeling of reconstituted high density lipoproteins and alter their reactivity with lecithin:cholesterol acyltransferase.
Durbin DM; Jonas A
J Lipid Res; 1999 Dec; 40(12):2293-302. PubMed ID: 10588955
[TBL] [Abstract][Full Text] [Related]
56. Relevance of the amino acid conversions L144R (Zaragoza) and L159P (Zavalla) in the apolipoprotein A-I binding site for haptoglobin.
Cigliano L; D'Andrea LD; Maresca B; Serino M; Carlucci A; Salvatore A; Spagnuolo MS; Scigliuolo G; Pedone C; Abrescia P
Biol Chem; 2008 Nov; 389(11):1421-6. PubMed ID: 18783334
[TBL] [Abstract][Full Text] [Related]
57. Positive allosteric modulators of lecithin: Cholesterol acyltransferase adjust the orientation of the membrane-binding domain and alter its spatial free energy profile.
Niemelä A; Koivuniemi A
PLoS Comput Biol; 2021 Mar; 17(3):e1008426. PubMed ID: 33720934
[TBL] [Abstract][Full Text] [Related]
58. rHDL modeling and the anchoring mechanism of LCAT activation.
Laurenzi T; Parravicini C; Palazzolo L; Guerrini U; Gianazza E; Calabresi L; Eberini I
J Lipid Res; 2021; 62():100006. PubMed ID: 33518511
[TBL] [Abstract][Full Text] [Related]
59. Copper- and malondialdehyde-induced modification of high density lipoprotein and parallel loss of lecithin cholesterol acyltransferase activation.
Mazière JC; Myara I; Salmon S; Auclair M; Haigle J; Santus R; Mazière C
Atherosclerosis; 1993 Dec; 104(1-2):213-9. PubMed ID: 8141845
[TBL] [Abstract][Full Text] [Related]
60. Trimerized apolipoprotein A-I (TripA) forms lipoproteins, activates lecithin: cholesterol acyltransferase, elicits lipid efflux, and is transported through aortic endothelial cells.
Ohnsorg PM; Mary JL; Rohrer L; Pech M; Fingerle J; von Eckardstein A
Biochim Biophys Acta; 2011 Dec; 1811(12):1115-23. PubMed ID: 21930241
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
